---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-26-000182"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2026-08-14T12:55:14+00:00"
generated_at: "2026-08-14T13:00:05.163589+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Labcorp EVP Bailey resigns; Caveney to lead Biopharma Lab Services

## Summary
- Megan D. Bailey resigns as EVP & President, Central Laboratories and International, effective Sept 4, 2026.
- Brian J. Caveney, M.D. becomes EVP & President, Biopharma Laboratory Services and Chief Medical & Scientific Officer on Sept 1, 2026.
- Caveney will oversee Early Development Research Laboratories and Central Laboratories businesses.
- Caveney previously led Early Development Research Laboratories and served as Chief Medical and Scientific Officer.

## SEC filing metadata
- accession: 0000920148-26-000182
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2026-08-14T12:55:14+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014826000182/0000920148-26-000182-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014826000182/lh-20260811.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-26-000182
- JSON: https://secwatch.observer/filing/0000920148-26-000182.json
- Plain text: https://secwatch.observer/filing/0000920148-26-000182.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.